GeneVia Technologies

GeneVia Technologies

Turku, Finland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Genevia Technologies is a private, revenue-generating bioinformatics services company based in Turku, Finland. It provides sophisticated data analysis as a service to life science researchers, leveraging a team with deep expertise across genomics, transcriptomics, epigenomics, and proteomics. The company serves a global clientele, including biotechs and academic institutions, helping them derive insights from complex biological data without needing in-house bioinformatics teams. Its business model is built on project-based consulting and long-term collaborative partnerships in high-growth research areas like precision oncology and single-cell analysis.

CancerImmunologyNeurologyGenetic DiseasesMetabolic DiseasesInfectious Diseases

Technology Platform

Integrated bioinformatics service expertise across multi-omics data types (genomics, transcriptomics, epigenomics, proteomics). Capabilities include analysis of DNA-seq, RNA-seq (bulk, single-cell, spatial), epigenomic arrays/seq, and mass-spec data, with a focus on data integration and interpretation.

Opportunities

The massive growth in complex omics data generation across academia and biopharma creates a sustained demand for expert analysis services.
The trend towards precision medicine and data-driven drug discovery further expands the need for sophisticated bioinformatics partnerships in key areas like immuno-oncology and single-cell biology.

Risk Factors

The business is highly dependent on recruiting and retaining scarce bioinformatics talent.
As a service-based model, scalability is limited compared to product-based companies, and revenues are subject to fluctuations in client research funding and budgets.
Competition from large CROs and automated software tools is ongoing.

Competitive Landscape

Genevia competes with other boutique bioinformatics consultancies, the in-house bioinformatics teams of large institutions, and the bioinformatics service arms of large Contract Research Organizations (CROs). Its differentiation lies in its deep scientific expertise, collaborative 'co-journey' service model, and broad, integrated omics capabilities, positioning it as a high-end expert partner rather than a generic service provider.